Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

San Antonio keeps rolling at the top as Detroit, Houston and Phoenix are among the big risers as Week 12 begins. San Antonio keeps rolling at the top as Detroit, Houston and Phoenix are among the big ...

Portable power stations are handy for backup power during outages, off-grid electricity for an RV, or simply charging your laptop and phone while working remotely. They’re effectively large bundles of ...

Generative AI is infiltrating everything you do online, including how you find information. If you're bored with traditional search, check out the top AI search engines we've tried. I’ve been writing ...

Are you worried about online privacy? Not a fan of anticompetitive practices? Maybe you just want a new take on web search? These 12 search engines beat Google in many ways. I've been testing PC and ...

Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Charlene Rhinehart is a CPA , CFE, chair of an Illinois CPA Society ...

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. Robert Kelly is managing director of XTS Energy LLC, and has ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Unwind by hunting for words on the day’s themed list — they’re hidden horizontally, vertically, diagonally and backward. Come back daily for a new theme or to browse the recent archive. Jump in to ...